GO:0002809 negative regulation of antibacterial peptide biosynthetic process: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002809 describes any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis, a key control point in bacterial competition and host defense.
• Antibacterial peptides are gene-encoded antibiotics produced by bacteria and other organisms, and their biosynthesis is often controlled by peptide pheromone-dependent regulatory circuits.
• Negative regulation of antibacterial peptide biosynthesis can occur at transcriptional, post-translational, and metabolic levels, as shown for 4-amino-4-deoxy-L-arabinose biosynthetic genes and cyclo(Phe-Pro) production.
• Lysine acetylation and other post-translational modifications modulate antibiotic resistance and peptide production pathways in Escherichia coli.
• Dysregulation of antibacterial peptide biosynthesis is linked to antibiotic resistance, altered microbiome competition, and bacterial virulence.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling antibacterial peptide biosynthesis.
Description
GO:0002809, negative regulation of antibacterial peptide biosynthetic process, is a Gene Ontology biological process term that captures any mechanism that stops, prevents, or reduces the production of antibacterial peptides. Antibacterial peptides are gene-encoded antibiotics, and their biosynthesis is a tightly controlled process in bacteria and other organisms. Understanding how this process is negatively regulated is important because antibacterial peptides mediate microbial competition, host defense, and antibiotic resistance. Peptide pheromone-dependent regulation of antimicrobial peptide production in Gram-positive bacteria exemplifies how multicellular behavior and quorum sensing intersect with peptide biosynthesis. In Escherichia coli, lysine acetylation has been implicated in antibiotic resistance, suggesting that post-translational modifications can influence peptide production and resistance phenotypes. Similarly, C4-dicarboxylates regulate cyclo(Phe-Pro) production, a peptide-based metabolite, highlighting metabolic control of peptide biosynthesis. The transcriptional regulation of 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis further illustrates how specific biosynthetic operons are controlled in response to environmental signals. Researchers study GO:0002809 to identify regulatory nodes that could be targeted to modulate antibacterial peptide output, combat resistance, or engineer peptide production. Because the term is defined broadly, it encompasses diverse molecular mechanisms, from transcriptional repressors to metabolic feedback and post-translational modification. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0002809, its mechanisms, key genes, disease relevance, and experimental models.
negative regulation of antibacterial peptide biosynthetic process At A Glance
| GO ID | GO:0002809 |
|---|---|
| GO term | negative regulation of antibacterial peptide biosynthetic process |
| Ontology | biological_process |
| Synonym | down regulation of antibacterial peptide biosynthetic process; down-regulation of antibacterial peptide biosynthetic process; downregulation of antibacterial peptide biosynthetic process; inhibition of antibacterial peptide biosynthetic process |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis. |
| Organism scope | Bacteria and other organisms that produce gene-encoded antibacterial peptides. |
| Regulatory inputs | Peptide pheromones, metabolic signals such as C4-dicarboxylates, and post-translational modifications including lysine acetylation. |
| Representative genes | Genes involved in 4-amino-4-deoxy-L-arabinose biosynthesis, cyclo(Phe-Pro) production, and antimicrobial peptide regulation. |
| Disease relevance | Antibiotic resistance, bacterial virulence, and microbiome competition. |
What Is GO:0002809?
GO:0002809 is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis. In other words, it is the negative regulatory arm of the biological process that produces antibacterial peptides, which are gene-encoded antibiotics. This term is a biological_process ontology annotation and includes synonyms such as down regulation of antibacterial peptide biosynthetic process, down-regulation of antibacterial peptide biosynthetic process, downregulation of antibacterial peptide biosynthetic process, and inhibition of antibacterial peptide biosynthetic process. The definition does not specify a particular organism or molecular mechanism; instead, it covers transcriptional, post-transcriptional, translational, and post-translational control that reduces peptide biosynthesis. Because antibacterial peptides are produced by diverse bacteria and other organisms, negative regulation can be mediated by peptide pheromones, metabolic signals, or resistance-modifying enzymes.
Why Is negative regulation of antibacterial peptide biosynthetic process Important in Cell Biology?
GO:0002809 is important because antibacterial peptides are central to microbial competition and host defense, and their biosynthesis must be tightly controlled to avoid wasteful or deleterious overproduction. Negative regulation of this process influences antibiotic resistance, as shown by the role of lysine acetylation in Escherichia coli antibiotic resistance. It also affects bacterial virulence and survival, as exemplified by the regulation of 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis. Understanding negative regulation provides targets for interventions that could either enhance peptide production for therapeutic purposes or suppress it to reduce resistance.
• Antibacterial peptides are gene-encoded antibiotics, and their biosynthesis is a key component of microbial warfare and host defense.
• Negative regulation prevents excessive or untimely peptide production, which can be metabolically costly.
• Peptide pheromone-dependent regulation in Gram-positive bacteria links peptide biosynthesis to multicellular behavior and quorum sensing.
• Lysine acetylation contributes to antibiotic resistance in Escherichia coli, connecting post-translational modification to peptide-related resistance.
• C4-dicarboxylates regulate cyclo(Phe-Pro) production, showing metabolic control of peptide biosynthesis.
• Transcriptional regulation of 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis affects outer membrane modification and resistance.
• Dysregulation of antibacterial peptide biosynthesis can alter microbiome composition and host-microbe interactions.
• Targeting negative regulators may provide strategies to overcome antibiotic resistance or engineer peptide production.
• GO:0002809 provides a framework for annotating and comparing regulatory mechanisms across bacterial species.
• CRISPR-based models enable causal testing of candidate negative regulators in relevant bacterial or host systems.
What Happens During negative regulation of antibacterial peptide biosynthetic process?
Transcriptional repression of peptide biosynthetic operons
In simple terms: The cell turns down the genes that make antibacterial peptides by blocking their transcription.
Negative regulation of antibacterial peptide biosynthesis often begins with transcriptional repression of the operons encoding peptide biosynthetic enzymes. In Yersinia pestis, the 4-amino-4-deoxy-L-arabinose biosynthetic genes are transcriptionally regulated in response to environmental signals, providing a paradigm for how biosynthetic gene clusters are controlled. Peptide pheromone-dependent regulation in Gram-positive bacteria also involves transcriptional control of antimicrobial peptide production, linking cell density signals to gene expression. These mechanisms ensure that peptide biosynthesis is activated only when appropriate and is reduced when conditions change.
Post-translational modification and enzyme inactivation
In simple terms: Even if the genes are on, the cell can modify the enzymes so they work less or not at all.
Post-translational modifications can negatively regulate peptide biosynthesis by altering the activity or stability of biosynthetic enzymes. Lysine acetylation has been implicated in antibiotic resistance in Escherichia coli, suggesting that acetylation of key enzymes or regulators can modulate peptide production and resistance phenotypes. Such modifications provide a rapid way to reduce biosynthetic flux without changing gene expression.
Metabolic and small-molecule feedback
In simple terms: Small molecules in the cell can act as signals to slow down peptide production.
Metabolic signals can negatively regulate antibacterial peptide biosynthesis. C4-dicarboxylates regulate cyclo(Phe-Pro) production, demonstrating that central metabolites can control peptide-based metabolite synthesis. This type of feedback allows the cell to coordinate peptide production with its metabolic state.
Peptide pheromone-dependent control
In simple terms: Bacteria talk to each other with small peptides, and those signals can turn down peptide production.
In Gram-positive bacteria, peptide pheromones regulate antimicrobial peptide production as part of multicellular behavior. Depending on the circuit, pheromone signaling can either activate or repress peptide biosynthesis, and negative regulation occurs when the signal reduces production. This quorum-sensing-like control ensures that peptide production is coordinated across the population.
Integration with resistance and stress responses
In simple terms: When bacteria face stress or antibiotics, they can adjust peptide production as part of a broader resistance response.
Negative regulation of antibacterial peptide biosynthesis is often integrated with stress and resistance responses. In Escherichia coli, lysine acetylation is linked to antibiotic resistance, indicating that post-translational regulatory networks can simultaneously affect peptide production and resistance. In Yersinia pestis, regulation of 4-amino-4-deoxy-L-arabinose biosynthetic genes affects outer membrane properties and resistance. These examples show that negative regulation is not isolated but part of a larger adaptive network.
Key Genes Involved in GO:0002809 negative regulation of antibacterial peptide biosynthetic process
The following genes and proteins are representative of the regulatory and biosynthetic machinery associated with negative regulation of antibacterial peptide biosynthetic process, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| p107 (RBL1) | Retinoblastoma family member regulated by calpain protease | Model for post-translational regulation of cell cycle and peptide-related pathways |
| SPOP | Prostate cancer-associated mutations stabilize BRD4 and confer BET inhibitor resistance | Example of how mutations in regulatory proteins affect drug resistance |
| BRD4 | Target of SPOP-mediated stabilization; involved in BET inhibitor resistance | Model for protein stability and resistance mechanisms |
| Peptide pheromone regulators (Gram-positive bacteria) | Control antimicrobial peptide production via multicellular behavior | Study of quorum sensing and peptide biosynthesis regulation |
| Lysine acetylation targets in E. coli | Modulate antibiotic resistance | Investigation of post-translational modification in resistance |
| Peptidoglycan and wall teichoic acid enzymes | Bacterial cell wall biogenesis | Structural and mechanistic studies of antibiotic targets |
| C4-dicarboxylate regulators | Control cyclo(Phe-Pro) production | Metabolic regulation of peptide biosynthesis |
| 4-amino-4-deoxy-L-arabinose biosynthetic genes (Yersinia pestis) | Transcriptional regulation of biosynthetic operon | Model for gene regulation and membrane modification |
| Calpain protease | Regulates p107 post-translationally | Study of proteolytic control of regulatory proteins |
| BET inhibitors | Drugs whose resistance is linked to SPOP mutations | Cancer therapy resistance models |
| Antimicrobial peptides (gene-encoded) | Antibacterial effectors | Study of gene-encoded antibiotics |
| Wall teichoic acid enzymes | Cell wall polymer biosynthesis | Antibiotic target research |
| Cyclo(Phe-Pro) | Peptide metabolite regulated by C4-dicarboxylates | Metabolic regulation studies |
| Yersinia pestis regulatory proteins | Control 4-amino-4-deoxy-L-arabinose genes | Virulence and resistance research |
| E. coli acetylation machinery | Modifies proteins to affect resistance | Post-translational modification studies |
| Gram-positive bacterial pheromone sensors | Detect peptide pheromones to regulate peptide production | Quorum sensing research |
How Is negative regulation of antibacterial peptide biosynthetic process Regulated?
The negative regulation of antibacterial peptide biosynthetic process is itself regulated by multiple inputs. Peptide pheromone-dependent circuits in Gram-positive bacteria integrate cell density signals to control antimicrobial peptide production. Metabolic signals such as C4-dicarboxylates regulate cyclo(Phe-Pro) production, linking central metabolism to peptide biosynthesis. Transcriptional regulators control the 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis in response to environmental cues. Post-translational modifications, including lysine acetylation, modulate antibiotic resistance and likely affect biosynthetic enzyme activity in Escherichia coli. These layers allow the cell to fine-tune peptide production in response to internal and external conditions.
negative regulation of antibacterial peptide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Lysine acetylation targets (E. coli) | Antibiotic resistance | Knockout of acetylation-related genes in E. coli |
| 4-amino-4-deoxy-L-arabinose biosynthetic genes (Yersinia pestis) | Outer membrane modification and resistance | Transcriptional reporter assays and knockout in Yersinia pestis |
| SPOP | Prostate cancer and BET inhibitor resistance | Point-mutation knock-in in cancer cell lines |
| p107 (RBL1) | Cell cycle regulation and calpain-mediated degradation | Overexpression and knockout in mammalian cells |
| Peptide pheromone regulators (Gram-positive bacteria) | Multicellular behavior and virulence | Knockout of pheromone sensor genes in Gram-positive bacteria |
Antibiotic resistance
Negative regulation of antibacterial peptide biosynthesis contributes to antibiotic resistance by reducing the production of peptides that would otherwise inhibit competing bacteria or host defenses. Lysine acetylation in Escherichia coli is linked to antibiotic resistance, suggesting that post-translational control of peptide-related pathways can promote resistance. The regulation of 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis affects outer membrane modification, which can influence resistance to antimicrobial peptides. Targeting these negative regulatory mechanisms may restore susceptibility to antibiotics.
Bacterial virulence and pathogenesis
Antibacterial peptides are important for bacterial competition and host defense, and their negative regulation can affect virulence. In Yersinia pestis, transcriptional control of the 4-amino-4-deoxy-L-arabinose biosynthetic operon is linked to membrane remodeling and resistance, which are relevant to pathogenesis. Peptide pheromone-dependent regulation in Gram-positive bacteria coordinates multicellular behaviors that can contribute to infection. Thus, dysregulation of peptide biosynthesis can alter the outcome of host-pathogen interactions.
Cancer and drug resistance (related regulatory principles)
Although GO:0002809 is a bacterial process, the regulatory principles of post-translational control and drug resistance are mirrored in cancer. For example, prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Similarly, posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease illustrates how proteolytic control affects cell cycle regulators. These examples highlight conserved themes of negative regulation and resistance that can inform cross-disciplinary research.
From negative regulation of antibacterial peptide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate antibacterial peptide biosynthesis? | CRISPR knockout of gene X in a peptide-producing bacterial strain |
| Does a specific point mutation alter negative regulation? | Point-mutation knock-in using CRISPR in the native locus |
| Can a tagged version of the regulator be used to study localization? | Knock-in of an epitope tag at the endogenous locus |
| Does overexpression of a candidate regulator reduce peptide production? | Overexpression plasmid or CRISPR activation in bacterial cells |
| Which metabolic signals control peptide biosynthesis? | Metabolic profiling combined with knockout of metabolic regulators |
| How does post-translational modification affect resistance? | Knockout of acetylation enzymes and antibiotic susceptibility testing |
How to Study the negative regulation of antibacterial peptide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of biosynthetic genes | Transcriptional regulation studies |
| Ribo-seq | Translation efficiency of peptide biosynthetic genes | Translational control analysis |
| Mass spectrometry proteomics | Post-translational modifications such as acetylation | Identifying modified enzymes in resistance |
| Metabolomics | Small-molecule signals like C4-dicarboxylates | Mapping metabolic regulation of peptide production |
| Western blotting | Protein stability and processing | Calpain-mediated p107 regulation |
| Antibiotic susceptibility testing | Resistance phenotype | Linking negative regulation to resistance |
| Reporter gene assays | Promoter activity of biosynthetic operons | Transcriptional regulation in Yersinia pestis |
| Competition assays | Fitness in mixed populations | Peptide-mediated competition |
Transcriptional and translational profiling
RNA-seq and Ribo-seq can measure changes in mRNA and translation of antibacterial peptide biosynthetic genes under conditions that activate or repress negative regulation. In Yersinia pestis, transcriptional regulation of the 4-amino-4-deoxy-L-arabinose biosynthetic genes was characterized using gene expression assays. In Gram-positive bacteria, peptide pheromone-dependent regulation of antimicrobial peptide production can be monitored by reporter fusions and transcriptomics.
Post-translational modification analysis
Proteomics and mass spectrometry can identify lysine acetylation and other modifications on biosynthetic enzymes. In Escherichia coli, lysine acetylation has been linked to antibiotic resistance, and such methods can reveal which proteins are modified. Calpain-mediated regulation of p107 demonstrates the importance of proteolytic processing, which can be studied by western blotting and degradation assays.
Metabolic and small-molecule profiling
Metabolomics can identify signals such as C4-dicarboxylates that regulate cyclo(Phe-Pro) production. By combining metabolite measurements with genetic perturbations, researchers can map feedback loops that negatively regulate peptide biosynthesis.
Genetic and phenotypic assays
Knockout, point-mutation, and overexpression models allow causal testing of candidate regulators. Antibiotic susceptibility testing and competition assays can then measure the functional impact on peptide production and resistance. Peptide pheromone-dependent regulation can be assayed using synthetic pheromones and reporter strains.
How CRISPR Can Be Used to Study GO:0002809 negative regulation of antibacterial peptide biosynthetic process
Knockout
CRISPR knockout can delete candidate negative regulators to test whether loss of function increases antibacterial peptide biosynthesis. For example, knocking out transcriptional repressors of the 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis would test their role in negative regulation. In Escherichia coli, knockout of acetylation-related genes can reveal effects on antibiotic resistance.
Point Mutation
Point-mutation knock-in using CRISPR can model specific amino acid changes in regulatory proteins. This is useful for studying how mutations in genes such as SPOP affect drug resistance and protein stability. In bacterial systems, point mutations in pheromone sensors can alter peptide production.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci allows visualization and biochemical analysis of negative regulators. Tagging biosynthetic enzymes in Yersinia pestis or Gram-positive bacteria can reveal localization and interactions. This approach preserves native regulation.
Overexpression
CRISPR activation or plasmid-based overexpression can test whether increased levels of a candidate regulator reduce peptide biosynthesis. Overexpression of metabolic regulators may suppress cyclo(Phe-Pro) production. In cancer models, overexpression of p107 or SPOP mutants can mimic disease-associated states.
How EDITGENE Supports negative regulation of antibacterial peptide biosynthetic process Research
Researchers studying negative regulation of antibacterial peptide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in controlling peptide production, resistance, or virulence. EDITGENE provides CRISPR-based cell models and screening services to enable such causal studies in relevant bacterial and mammalian systems.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of antibacterial peptide biosynthetic process research.
Frequently Asked Questions About negative regulation of antibacterial peptide biosynthetic process
What is GO:0002809?
GO:0002809 is the Gene Ontology term for negative regulation of antibacterial peptide biosynthetic process, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis.
What are antibacterial peptides?
Antibacterial peptides are gene-encoded antibiotics produced by bacteria and other organisms that can inhibit the growth of competing microbes.
What genes are involved in negative regulation of antibacterial peptide biosynthetic process?
Genes involved include those encoding peptide pheromone sensors in Gram-positive bacteria, transcriptional regulators of the 4-amino-4-deoxy-L-arabinose biosynthetic operon in Yersinia pestis, and acetylation-related enzymes in Escherichia coli.
How is antibacterial peptide biosynthesis negatively regulated?
It can be negatively regulated at transcriptional, post-translational, and metabolic levels, for example by peptide pheromones, lysine acetylation, and C4-dicarboxylates.
Why is negative regulation of antibacterial peptide biosynthesis important?
It prevents wasteful overproduction, coordinates microbial competition, and influences antibiotic resistance and virulence.
What diseases are linked to antibacterial peptide regulation?
Antibiotic resistance and bacterial virulence are directly linked, and related regulatory principles apply to cancer drug resistance.
What model systems are used to study GO:0002809?
Common models include Gram-positive bacteria, Escherichia coli, Yersinia pestis, and mammalian cell lines for conserved regulatory mechanisms.
How can CRISPR help study negative regulation of antibacterial peptide biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of candidate regulators in native or heterologous systems.
What methods measure antibacterial peptide biosynthesis?
RNA-seq, Ribo-seq, proteomics, metabolomics, and antibiotic susceptibility testing are commonly used.
Does EDITGENE provide services for GO:0002809 research?
Yes, EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for studying this process.
Conclusion
GO:0002809, negative regulation of antibacterial peptide biosynthetic process, is a critical biological process that controls the production of gene-encoded antibiotics. It operates through transcriptional repression, post-translational modification, metabolic feedback, and peptide pheromone signaling. Dysregulation of this process contributes to antibiotic resistance and bacterial virulence, making it a target for therapeutic intervention. CRISPR-based models and multi-omics methods provide powerful tools to dissect the underlying mechanisms and identify new regulatory nodes. EDITGENE supports this research with custom cell models and screening services.
References
- 1. Sahl HG. 1994. Gene-encoded antibiotics made in bacteria.. Ciba Found Symp 186:27-42; discussion 42-53 PMID: 7768156
- 2. Jang JS et al.. 1999. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease.. Oncogene 18(10):1789-96 PMID: 10086333
- 3. Dai X et al.. 2017. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.. Nat Med 23(9):1063-1071 PMID: 28805820
- 4. Kleerebezem M et al.. 2001. Peptide pheromone-dependent regulation of antimicrobial peptide production in Gram-positive bacteria: a case of multicellular behavior.. Peptides 22(10):1579-96 PMID: 11587786
- 5. Fang Z et al.. 2022. Potential Role of Lysine Acetylation in Antibiotic Resistance of Escherichia coli.. mSystems 7(6):e0064922 PMID: 36286553
- 6. Caveney NA et al.. 2018. Enzyme structures of the bacterial peptidoglycan and wall teichoic acid biogenesis pathways.. Curr Opin Struct Biol 53:45-58 PMID: 29885610
- 7. Xu X et al.. 2024. Regulatory mechanism of C4-dicarboxylates in cyclo (Phe-Pro) production.. Microb Cell Fact 23(1):255 PMID: 39342283
- 8. Winfield MD et al.. 2005. Transcriptional regulation of the 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis.. J Biol Chem 280(15):14765-72 PMID: 15710615
